Results 1 to 10 of about 17,290 (146)

Gabapentin for refractory chronic cough [PDF]

open access: yesLancet, The, 2013
www.thelancet.com Vol 381 February 23, 2013 623 Submissions should be made via our electronic submission system at http://ees.elsevier.com/ thelancet/ pneumonia. Indeed, in our outpatient clinics in Yaita (Tochigi Prefecture) and Kashiwa (Chiba Prefecture), about 20% of patients complaining of persistent cough between June and October, 2012, were ...
Ken-Ichiro Inoue
exaly   +9 more sources

Cough desensitization treatment for patients with refractory chronic cough: results of a second pilot randomized control trial [PDF]

open access: yesBMC Pulmonary Medicine, 2023
Objective The purpose of this study was to collect pilot efficacy data on a novel treatment for refractory chronic cough (RCC), which we call cough desensitization treatment (CDT).
Laurie J. Slovarp   +5 more
doaj   +2 more sources

Management of non-pharmacologic therapy for chronic refractory cough: Mechanism, composition, applicable population, and assessment

open access: yesHeliyon, 2023
Chronic cough is common in the clinic and can seriously affect the quality of life of patients. Following the existing guidelines for treatment, refractory chronic cough is defined as a clinical condition in which the cause of the cough remains unclear ...
Yanzi Peng   +4 more
doaj   +3 more sources

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial [PDF]

open access: yesRespiratory Research, 2023
Background P2X3 receptor antagonists seem to have a promising potential for treating patients with refractory chronic cough. In this double-blind, randomized, placebo-controlled study, we investigated the efficacy, safety, and tolerability of the novel ...
Christian Friedrich   +10 more
doaj   +2 more sources

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough [PDF]

open access: yesERJ Open Research, 2022
Objective Baclofen is a centrally acting γ-aminobutyric acid type B (GABAB) receptor agonist which reduces gastro-oesophageal reflux and suppresses the cough reflex; however, central nervous system side-effects limit its use.
Huda Badri   +17 more
doaj   +2 more sources

An observational study to understand burden and cost of care in adults diagnosed with refractory chronic cough (RCC) or unexplained chronic cough (UCC) [PDF]

open access: yesRespiratory Research
Background Refractory and unexplained chronic cough (RCC and UCC) necessitate frequent referral for specialist evaluations, but data on healthcare resource utilisation and costs are lacking.
Jaclyn A. Smith   +9 more
doaj   +2 more sources

Reframing Refractory Chronic Cough: The Role of Interoception. [PDF]

open access: yesLung
Refractory chronic cough (RCC) remains a persistent clinical challenge, often resistant to traditional treatments. Emerging evidence now positions RCC as a disorder rooted in hypersensitivity, driven primarily by central neural processes rather than external physiological causes. Central to this understanding is the concept of interoception-the brain's
Slovarp LJ   +3 more
europepmc   +3 more sources

Inhaled alkaline hypertonic divalent salts reduce refractory chronic cough frequency [PDF]

open access: yesERJ Open Research
Background Treatment of chronic cough remains a challenge. We hypothesised that inhaled alkaline hypertonic divalent salts (alkaline HDS) might provide relief for refractory chronic cough by laryngeal and tracheal hydration.
Hisham Abubakar-Waziri   +6 more
doaj   +2 more sources

Prevalence of refractory and unexplained chronic cough in adults treated in cough centre

open access: yesERJ Open Research
Background Refractory chronic cough and unexplained chronic cough pose significant clinical challenges, impairing patients’ quality of life. However, a precise definition of refractory chronic cough remains elusive.
Paweł Kukiełka   +4 more
doaj   +3 more sources

Gabapentin for chronic refractory cough: A system review and meta-analysis

open access: yesHeliyon, 2023
Objective: To evaluate the efficacy and safety of gabapentin in the treatment of chronic refractory cough by Meta-Analysis. Methods: Literatures were retrieved from PubMed, Embase (OvidIP), Cochrane Library, CNKI, VIP, Wanfang Database and China ...
Sheng Xie   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy